TIMOTHY BARNES: Open Payments
NPI 1932742210 · CHEYENNE, WY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$572 in 26 payments from 8 companies in 2025. Trend: 2023 $948 · 2024 $513 · 2025 $572
Food & beverage: $572
| Company | Payments | Amount |
|---|---|---|
| Lundbeck LLC | 9 | $223 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 10 | $210 |
| Supernus Pharmaceuticals, Inc. | 2 | $38 |
| Collegium Pharmaceutical, Inc. | 1 | $23 |
| E.R. Squibb & Sons, L.L.C. | 1 | $23 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $21 |
| Neurocrine BioSciences, Inc. | 1 | $18 |
| Otsuka America Pharmaceutical, Inc. | 1 | $17 |
Products named: REXULTI, CAPLYTA, Qelbree, Jornay PM, COBENFY, TRINTELLIX, INGREZZA.
Industry payments across WY — which companies pay providers there.
